Surgical neurology international · 2025
BurstDR spinal cord stimulation for chronic inflammatory demyelinating polyneuropathy.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iovenko Dmytro, Jaffee Stephen, Patterson Michael, Tomycz Nestor
Аннотация
BACKGROUND: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological disorder in which the immune system attacks the myelin sheath, leading to progressive muscle weakness and sensory loss. Neuropathic pain is a common and often debilitating symptom in patients with CIDP. Treatment options include immunoglobulin therapy and, in refractory cases, spinal cord stimulation (SCS).
CASE DESCRIPTION: We present the case of a 70-year-old male with CIDP who experienced severe neuropathic pain in a stocking distribution affecting both lower extremities. He had previously been treated with intravenous immunoglobulin with limited relief of his pain symptoms. Due to persistent, debilitating neuropathic pain despite ongoing immunotherapy, he underwent implantation of a thoracic paddle spinal cord stimulator. At 3-month postoperative follow-up, he reported a 75% reduction in pain intensity.
CONCLUSION: BurstDR paddle lead SCS may offer significant pain relief in patients with CIDP-associated neuropathic pain and should be considered as part of a multidisciplinary treatment.
CASE DESCRIPTION: We present the case of a 70-year-old male with CIDP who experienced severe neuropathic pain in a stocking distribution affecting both lower extremities. He had previously been treated with intravenous immunoglobulin with limited relief of his pain symptoms. Due to persistent, debilitating neuropathic pain despite ongoing immunotherapy, he underwent implantation of a thoracic paddle spinal cord stimulator. At 3-month postoperative follow-up, he reported a 75% reduction in pain intensity.
CONCLUSION: BurstDR paddle lead SCS may offer significant pain relief in patients with CIDP-associated neuropathic pain and should be considered as part of a multidisciplinary treatment.